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Simple Summary: Carbon nanotubes are revolutionary materials with applications in a lot of dif-
ferent areas. However, there is a rising concern regarding unlikely toxicity effects these materials
may trigger. Due to this, the main aim of this paper is to develop a comprehensive approach to study
toxicity effect of carbon nanotubes on the mitochondria F0F1-ATPase. We have employed a combina-
tion of experimental and computational study. In so doing, we have combined in vitro inhibition
responses in submitochondrial particles with docking elastic network models, fractal surface analysis,
and Nano-quantitative structure toxicity relationship models (Nano-QSTR models). Results show
that this method may be used for the fast prediction of the nanotoxicity induced by single walled
carbon nanotubes (SWCNT), avoiding time- and money-consuming techniques, and may open new
avenues toward to the better understanding and prediction of new nanotoxicity mechanisms.
Abstract: Single-walled carbon nanotubes can induce mitochondrial F0F1-ATPase nanotoxicity
through inhibition. To completely characterize the mechanistic effect triggering the toxicity, we have
developed a new approach based on the combination of experimental and computational study,
since the use of only one or few techniques may not fully describe the phenomena. To this end,
the in vitro inhibition responses in submitochondrial particles (SMP) was combined with docking,
elastic network models, fractal surface analysis, and Nano-QSTR models. In vitro studies sug-
gest that inhibition responses in SMP of F0F1-ATPase enzyme were strongly dependent on the
concentration assay (from 3 to 5 µg/mL) for both pristine and COOH single-walled carbon nan-
otubes types (SWCNT). Besides, both SWCNTs show an interaction inhibition pattern mimicking
the oligomycin A (the specific mitochondria F0F1-ATPase inhibitor blocking the c-ring F0 subunit).
Performed docking studies denote the best crystallography binding pose obtained for the docking
complexes based on the free energy of binding (FEB) fit well with the in vitro evidence from the
thermodynamics point of view, following an affinity order such as: FEB (oligomycin A/F0-ATPase
complex) = −9.8 kcal/mol > FEB (SWCNT-COOH/F0-ATPase complex) = −6.8 kcal/mol ~ FEB
(SWCNT-pristine complex) = −5.9 kcal/mol, with predominance of van der Waals hydrophobic
nano-interactions with key F0-ATPase binding site residues (Phe 55 and Phe 64). Elastic network
models and fractal surface analysis were performed to study conformational perturbations induced
by SWCNT. Our results suggest that interaction may be triggering abnormal allosteric responses and
signals propagation in the inter-residue network, which could affect the substrate recognition ligand
geometrical specificity of the F0F1-ATPase enzyme in order (SWCNT-pristine > SWCNT-COOH).
In addition, Nano-QSTR models have been developed to predict toxicity induced by both SWCNTs,
using results of in vitro and docking studies. Results show that this method may be used for the fast
prediction of the nanotoxicity induced by SWCNT, avoiding time- and money-consuming techniques.
Overall, the obtained results may open new avenues toward to the better understanding and pre-
diction of new nanotoxicity mechanisms, rational drug design-based nanotechnology, and potential
biomedical application in precision nanomedicine.
Biology 2021, 10, 171. https://doi.org/10.3390/biology10030171 https://www.mdpi.com/journal/biology
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1. Introduction
The coupled mechanical co-rotating between the γ and ε subunits that form the mi-
tochondrial F1-ATP synthase (complex V) favors the H+ protons flux necessary for ATP
synthesis in all eukaryotic cells [1,2]. This bioenergetic process involves several synchro-
nized conformational changes which are critical for the survival or death of the cells [1].
In this regard, a few years ago, it was shown that under pathological conditions like chronic
diseases such as cancer, Alzheimer’s disease, Parkinson’s disease, and mitochondrial
encephalopathy, lactic acidosis (MELAS) syndrome, several toxic events, including nan-
otoxicity induced by single walled carbon nanotubes (SWCNT), may trigger F0F1ATPase
dysfunction [3,4]. As a consequence, the ATP cellular reserves are abruptly consumed
by a reverse biochemical reaction which paradoxically hydrolyses significant amounts of
ATP, compromising the cellular homeostasis and viability [3,5,6]. Several chemical agents
(including carbon nanoparticles) have shown a high affinity/selectivity by the bioenergetic
mechanisms based on ATP hydrolysis, particularly nanoparticle-based single-walled car-
bon nanotubes (SWCNTs), which have been studied by their selective nanotoxicity effects
on mitochondria (mitotropic behavior) [7–10].
To the best of our knowledge, the toxicological modulation of mitochondrial ATP
bioenergetic mechanisms released by the exposure with SWCNT-pristine and oxidized-
SWCNT (SWCNT-COOH) have been insufficiently characterized in order to explain the
mitochondrial nanotoxicity induced by SWCNT. On the other hand, this mechanistic knowl-
edge could be very useful to implement strategies on the named “precision mitochondrial
nanomedicine” to improve selectivity for the treatment of brain, cardiac diseases, and can-
cer using the mitotropic behavior of SWCNT to address active pharmacological principles
as new targeting of the mitochondrial F0F1-ATPase [9–14]. In this context, we hypothe-
size that SWCNT-pristine could act by mimicking the pharmacodynamic behavior of the
Oligomycin A, which is the specific inhibitor of the mitochondrial ATP-hydrolysis that
modulates the activity of the c-ring-F0-ATP hydrolase subunit. However, in the case of
the SWCNT-COOH, the F0-ATPase binding interaction could be more attenuated by the
presence of the carboxyl group.
From the structural point of view, the c-ring-F0-ATP hydrolase subunit represents
an uncoupling channel which is part of the mitochondrial permeability transition pore-
induced association to mitochondrial dysfunction and apoptosis [15,16]. Following this
idea, we suggest that SWCNT could promote the selective inhibition of the F0-ATPase
under pathological conditions like cancer where the F0F1-ATPase activity is abnormally
exacerbated [16–19].
In this regard, computational approaches like molecular docking simulation, elas-
tic network models, fractal surface approaches linked to nano-quantitative structure–
activity/toxicity relationships (Nano-QSAR/QSTR models), and others [9,20–23], could be
efficiently applied to the exhaustive exploration of the underlying mechanisms of mito-
chondrial bioenergetic dysfunction (pathological ATP-hydrolysis) from the structural point
of view for therapeutic purposes.
Protein structures cannot be investigated using the classical Euclidian mathematical
approach. Due to this nature, surface and protein’s chain should be studied using the
fractal approach. It is well-known that the fractal dimensions (FDs) are directly associated
to the backbone non-Euclidean geometry, as well as to the irregular geometric nature and
fractal surface properties of the binding sites (ATPaseF0F1 binding sites). This is explained
by the fact that most of the ligand–protein binding processes occur under strict conditions
of specificity and, at the same time, that these thermodynamic processes depend on surface
phenomena with a defined geometric pattern of stereospecificity and complementarity
with the cited binding sites [24]. For this instance, we thus suggest that small changes in the
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fractal geometry-based surface patterns could directly affect not only the native ATPaseF0F1
binding sites’ folding and solvent accessible surface in the unbound state (unoccupied
ATPaseF0F1), but also the conformational entropy and thermodynamic stability of the
formed docking complexes generated between the ATPaseF0F1 and the different single-
walled carbon nanotubes tested [24,25]. In addition, elastic network models may also be
used to study proteins since they may be able to predict global dynamics of proteins and
proteins’ complexes [26–28]. Thus, these two methods can be used, together with other
methods, to study conformational changes induced by SWCNT that may produce harmful
effects, inactivation, and so on.
Another relevant approach to study toxicity is computational nano-quantitative
structure–activity/toxicity relationships (nano-QSAR/QSTR), which are essential tools to
support the discovery process of toxicological effects of nanomaterials (SWCNT). Several
approaches have been developed and applied recently to predict potential harmfulness
of nanoparticles and nanomaterials [9–14,29]. These in silico tools have the quality of
being versatile and reconfigurable to many problems. For example, the nano-quantitative
structure–binding relationship (Nano-QSBR) models are a type of Nano-QSTR which are
able to associate the physico-chemical properties of nanomaterials (nano-descriptors) with
the theoretical free energy of binding (FEB values, kcal/mol) obtained from the molecular
docking studies and also to experimental nanotoxicological outputs [13,14,30].
Due to this, the QSAR (Nano-QSTR) paradigm has been applied since the beginning
of the “nano revolution” as a useful methodology able to support toxicity profiling of
nanomaterials and CNT [31–35]. Several approaches by many authors have been reported
combining different molecular descriptors, methodologies, and algorithms, including
machine learning and deep learning [34–42]. In this sense, it is strongly advisable to use
Nano-QSTR approaches while performing toxicity profiling of CNT and nanomaterials,
since they may be able to predict toxicity as well as directly correlate toxicity/activity
with specific features of nanomaterials. In addition, in silico approaches are strongly
encouraged by national and supranational authorities in the light of the European Union
(EU) 3R principles (replacement, reduction, refinement). Currently, the main limitation
of these computational methods is to address a feasible mechanistic interpretation of the
nanotoxicity phenomena at the atomic level, in many cases [43].
In this work, we propose for the first time a combination of computational modeling
approaches, based on molecular docking simulations, elastic network models, fractal
surface approaches, and Nano-QSTR calculations, along with experimental validation to
tackle the study of binding interactions between single-walled carbon nanotubes with the
mitochondrial F0F1-ATPase to contribute to the rational drug design-based nanotechnology,
mitotarget drug discovery, and the new area of precision mitochondrial nanomedicine.
2. Materials and Methods
2.1. Experimental Section
2.1.1. Reagents and Solutions
Sucrose, ethylene-glycol-bis (b-aminoethyl)-N,N,N0,N0-tetraacetic acid (EGTA), potas-
sium succinate (plus 2 mM rotenone), K2HPO4, and piperazine-N-2-ethanesulfonic acid
(Hepes), dimetilsulfóxido (DMSO), and Biuret reagent. All other reagents were commer-
cial products of the highest purity grade available. Single-walled carbon nanotubes like
SWCNT-pristine and carboxylated-CNT (SWCNT-COOH) with very low conductivity and
semi-metallic properties were provided by Cheaptubes Company (http://cheaptubes.com/
shortohcnts.htm) for the execution of experimental in vitro assays using submitochondrial
particles. All other reagents were commercial products of the highest purity grade available
and were purchased from Sigma-Aldrich products
2.1.2. Carbon Nanotubes’ Characterization
For this instance, a Transmission Electron Microscope (TEM, Tecnai G2-12-SpiritBiotwin
FEI-120 kV) was used to characterize the morphology of SWCNT-pristine and oxidized
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carbon nanotubes such as SWCNT-COOH. The CNT were synthesized by using a catalytic
chemical vapor deposition (CCVD) method and functionalized using a concentrated acid
mixture of H2SO4:HNO3 mixed (2:1). On the other hand, in order to discover the molec-
ular mechanisms of interaction inhibition of the carbon nanotubes with the F0-ATPase,
two types of single-walled carbon nanotubes (SWCNT-pristine and SWCNT-COOH) were
modeled by using the Avogadro software, which can be efficiently applied as an advanced
molecule editor and visualizer for molecular modeling and computational chemistry.
Herein, it is important to note that the in silico analysis was performed just for the purpose
of proposing a theoretically rigorous mechanism to explain the potential inhibition of the
single-walled carbon nanotubes used on the F0-ATP-ase inhibition. For this reason, the the-
oretically modeled SWCNTs should not be taken as exact copies from the structural point of
view compared with the experimentally tested CNT (SWCNT-pristine and SWCNT-COOH)
used in in vitro assays. In this sense, for computational purposes, several approximations
were performed mainly based on the diameter and length of carbon nanotubes theoretically
modeled compared with those experimentally evaluated, see Figure 1.
Figure 1. On the right, Transmission Electron Microscope (TEM) images obtained of carbon nanotubes, such as (A) SWCNT-
pristine and (B) SWCNT-COOH used in this study for the experimental in vitro assay. On the left, (C) representation of
the length of the unoccupied F0-ATPase binding site, (D,E) representation of the lengths of the theoretically modeled
SWCNT-pristine and SWCNT-COOH within the F0-ATPase used for the in silico assay of F0-ATPase inhibition. Additional
details can be found in the Supplementary Information in Figure S1.
2.1.3. Isolation of Rat Liver Submitochondrial Particles (SMP)
The frozen rat liver mitochondria (RLM) pellet was thawed and diluted with ho-
mogenization medium to contain 20 mg of protein/mL. The mitochondrial suspension
was subjected to sonic oscillation four times for 15 s with 30 s intervals, using 80 watts at
4 ◦C [44–47]. The suspension was then centrifuged at 9750× g for 10 min at 4 ◦C and the
submitochondrial particles in the supernatant were isolated by additional centrifugation in
a Sorval SV-80 vertical rotor for one hour at 15,000 rev/min at 4 ◦C, using discontinuous
gradient containing 1 mL of 0.5 M sucrose and 1 mL of 2.0 M sucrose in 5 mM Tris-HCl,
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pH 7.4. Finally, the SMP were suspended in the isolation medium, and the final volume
was adjusted to give a stock suspension containing 1 mg of protein/mL.
2.1.4. Standard Incubation Procedure
Mitochondria liver was isolated and submitochondrial particles (SMP) were energized
with 5 mM of potassium succinate (plus 2.5 µM of rotenone) in a standard incubation
medium consisting of 125 mM of sucrose, 65 of mM KCl, 2 mM of inorganic phosphate
(K2HPO4), and 10 mM of HEPES-KOH, pH 7.4, at 30 ◦C [44–47].
2.1.5. Determination of Mitochondrial F0F1-ATPase Inhibition in Isolated Rat Liver
Submitochondrial Particles (SMP)
Isolated rat liver submitochondrial particles (isolated-F0F1-ATPase) (20 mg of pro-
tein) were incubated according to the following experimental groups: (1) untreated SMP,
(2) SMP + DMSO (100 mM), (3) SMP + SWCNT samples (SWCNT-pristine, SWCNT-COOH)
in the range of concentration of 0.5–5 µg/mL, (4) SMP + Oligomycin A (1 µM) as a pos-
itive control, and (5) SMP + Oligomycin A (1 µM) + SWCNT samples at 5 µg/mL as an
additional control assay. The reactions are started by addition of enzyme, such as H+-c-
ring/F0-ATPase (80 µg of protein). The total volume was 1 mL. After 10 min at 37 ◦C,
the reaction was stopped by addition of 0.5 trichloroacetic acid, 30% (w/v). Phosphate
released by ATP hydrolysis is measured on 0.5 mL of molybdate reagent (10 mM ammo-
nium molybdate in 2.5 M sulfuric acid), 1 mL of acetone, and 0.5 mL of 0.4 M citric acid.
After each addition, the tubes are homogenized for 10 s in a vortex mixer. The mitochon-
drial F0F1-ATPase inhibition (F0-ATPase inhibition) for each treatment was calculated by
measuring the absorbance at 355 nm [44–47]. Before all spectrophotometric F0-ATPase inhi-
bition measurements, the blanks with each SWCNT were run and interference absorbance
peaks of SWCNT were not observed at 300–400 nm [44–47]. Furthermore, each SWCNT
sample was added under continuous stirring by using magnetic stirrer cuvettes with the
aim of preventing the agglomeration process for the SWCNTs during the F0F1-ATPase
inhibition assay. For this instance, a tip-sonication regime during 5–10 min was applied
which prevents the SWCNT exfoliation into individual SWCNT samples (SWCNT-pristine,
SWCNT-COOH), generating a non-agglomerated suspension in monodisperse state before
exposure to submitochondrial particle suspension [48–50].
2.1.6. Statistical Procedures for the Mitochondrial Assays Using SMP
The one-way analysis of variance (ANOVA) followed by a post hoc Newman–Keuls
multiple comparison test was used in order to determine statistical differences between
F0-ATPase inhibition assays as independent unrelated experimental groups. In this context,
the Newman–Keuls test was used as a multiple and tiered comparison procedure to iden-
tify experimental group statistical means that are significantly different from each other
from the different experimental conditions evaluated, namely: (i) untreated submitochon-
drial particles control (SMP as F0-ATPase), (ii) DMSO-treated SMP, (iii) CNT-treated SMP
(i.e., SWCNT-pristine or SWCNT-COOH at 1–5 µg/mL), (iv) Oligomycin A-treated SMP
(Oligomycin A is a specific F0F1-ATPase inhibitor used as a positive control), and (v) treated
SMP mixed with SWCNT or SWCNT-COOH at concentration of 5 µg/mL + Oligomycin A
(1 µM). All the biochemical tests, by using isolated rat liver mitochondria (RLM) and sub-
mitochondrial particles (SMP), were performed at least three times in triplicate. Normality
and variance homogeneity were verified using Shapiro–Wilks and Levene tests respectively,
before using one-way ANOVA. In all cases, significance level was set at 5%.
2.2. Theoretical Section
2.2.1. Molecular Docking Study
Docking simulations were performed using Autodock tools mixed Autodock Vina to
understand the strength of biochemical interactions across CNT family members (SWCNT-
pristine and oxidized-CNT (SWCNT-COOH)) and oligomycin A on F0-ATPase. These in
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silico binding interactions were performed only to explain hidden biophysical and phar-
macodynamic mechanisms observed in the mitochondrial in vitro assays. For this instance,
only two types of single walled zigzag SWCNTs (Hamada index n = 8, m = 0) were
modeled, like SWCNT (8.0) and SWCNT-COOH (8.0) as F0F1-ATPase ligands in order to
reproduce and model some critical experimental conditions from CNT-properties, like CNT-
functionalization linked to observed F0-ATPase inhibition (ATP-hydrolysis inhibition) in
isolated RLM and isolated SMP. Following this idea, the F0F1-ATPase C10 ring with
oligomycin A from yeast (Saccharomyces cerevisiae) as the receptor (protein data bank (PDB)
ID: 5BPS, Resolution 2.1Å) was obtained from the RCSB Protein Data Bank (PDB) [51]. It is
important to note that c-ring-F0-ATPase subunit PDB X-ray structure from Saccharomyces
cerevisiae (5BPS) can be used in the context of the present docking approaches, taking into
account that mitochondrial c-ring-F0-ATPase subunit PDB X-ray structure from Rattus
norvegicus with oligomycin A has not been crystallized and included in the RCSB PDB [51].
However, the oligomycin A pharmacodynamics mechanism is highly conserved in Rattus
norvegicus according to previous experimental evidences [17].
Before the molecular docking, ATPase C10 ring molecular structure was optimized
using the AutoDock Tools 4 software for AutoDock Vina. The algorithm includes the
removal of crystallographic water molecules and all the co-crystallized ATPase C10 ring
ligand molecules, such as oligomycin A (Oligo A: C45H74O11 ID: EFO) from ATPase C10
ring chains (B, E, K, L, M, O). Oligomycin A is a recognized classical inhibitor of F0F1-
ATPase inhibition and it was used as a control to compare the affinity and/or relevant
interactions by the re-docking procedure.
This theoretical algorithm was performed to the c-ring F0-ATPase subunit using a grid
box size with dimensions of X = 22 Å, Y = 22 Å, and Z = 22 Å, and the c-ring F0-ATPase
subunit grid box center X = 19.917 Å, Y = 19.654 Å, and Z = 29.844 Å to evaluate the
interaction of SWCNT + c-ring–F0-ATPase [52], considering the oligomycin A environment
to evaluate the SWCNT-surface affinity in the c-ring F0-ATPase subunit active binding site.
The docking free energy of binding output results (or FEB values) is defined by affinity
(like ∆Gbind values) for all docked poses of the formed complexes (SWCNT-F0ATPase)
and includes the internal steric forces of a given ligand (SWCNT), which can be expressed
as the sum of individual molecular mechanics terms of standard chemical potentials
as: van der Waals interactions (∆GvdW), hydrogen bond (∆GH-bond), electrostatic inter-
actions (∆Gelectrost), and intramolecular interactions (∆Ginternal) ligands (SWCNTs) from
empirically validated Autodock Vina scoring function based on default Amber force-field
parameters [20–22].
2.2.2. Local Perturbation Response Induced by SWCNT on the F0-ATPase Subunit
In parallel with docking simulation, a new elastic network model was performed to
propose a potential mechanism based on the SWCNT propensity to perturb the intrinsic
motion of F0-ATPase subunit binding residues involved in the docking interactions. For this
purpose, the F0-ATPase is represented as a network or graph of the inter-residue contacts
from Cα-F0-ATPase atoms of a residue and the overall potential is simply the sum of
harmonic potentials between interacting nodes (F0-ATPase residues). The network includes
all interactions within a cutoff distance < 4 Å. Information about the orientation of each
interaction with respect to the global coordinates system is considered within the force
constant matrix and allows prediction of perturbed anisotropic motions [53]. The force
constant of the F0-ATPase protein system can be described by a Kirchhoff or Hessian matrix
(Hi,j) to evaluate potential perturbations induced by the SWCNT ligand in the transduction
properties of the F0-ATPase enzyme according to the following Equation (1):
Hij =

H1,1 H1,2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . H1,N
H2,1 H2,2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . H2,N
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
HN,1 HN,2 . . . . . . . . . . . . . . . . . . . . . . . . . HN.N
 (1)
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where each Hi,j is a 3 × 3 matrix which holds the anisotropic information regarding the
orientation of residues (i, j nodes). Each such sub-matrix (or the “super element” of the Hi,j
Hessian matrix) is defined by the Equation (2) as:
Hij =
 δ2V/δXiδXj δ2V/δXiδYj δ2V/δXiδZjδ2V/δYiδXj δ2V/δYiδYj δ2V/δYiδZj
δ2V/δZiδXj δ2V/δZiδYj δ2V/δZiδZj
 (2)
The second partial derivatives are the harmonic potentials, V, between interacting
F0-ATPase residues. These partial derivatives are formed by a simple matrix of cosines























where γ = 0.5 is an interaction constant. The si,j is the instantaneous distance between






Herein, the force constant matrix Hi,j holds information regarding the F0-ATPase-
residues position/orientation. The inverse of the Hessian matrix is the covariance matrix
of 3N multi-variant Gaussian distribution, where p is an empirical parameter according
to the Equation (5) for the new off-diagonal elements of the Hessian matrix which hold
the desired information on the residue fluctuations, including the F0-ATPase binding site











































Then, we tackle the construction of the local perturbation response scanning maps
(LPRS maps) by setting the following conditions: (i) unbound F0-ATPase as the control
simulation experiment, (ii) oligomycin A + F0-ATPase, (iii) SWCNT-pristine + F0-ATPase,
and (iv) SWCNT-COOH + F0-ATPase.
2.2.3. Performing Nano-QSTR Approaches
The Nano-QSTR models have been developed using a linear regression approach to
predict the mitochondrial F0F1-ATPase inhibition values of the SWCNT studied herein.
The values used for the development of the continuous model were obtained from molec-
ular docking experiments considering the free energy of binding (FEB values) obtained
from the complexes SWCNT-pristine/F0-ATPase and SWCNT-COOH/F0-ATPase. For this
purpose, two different sets for both ligands (SWCNT-pristine, SWCNT-COOH) were ef-
ficiently built. Considering the three recognized categories of geometric topologies as:
zigzag-SWCNT (Hamada index m = 0, n > 0), amchair-SWCNT (Hamada index m = n),
and chiral-SWCNT, characterized by the Hamada index (n, m), with m > 0 and m 6= n,
and with its enantiomers (or mirror images), presenting the Hamada index (m, n), which is
different from (n, m), with no reflection symmetry [13,14]. Then, regression Nano-QSTR
models were developed using the linear regression tool implemented in the Statistica® suite.
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The validation of the Nano-QSTR model was performed using the cross-validation
module implemented in the software. This procedure is aimed at assessing the predictive
accuracy of a model. The test randomly split the dataset into a training set and a validation
set, ensuring that if an entry was included in the test set it could not be used in the
validation set. In so doing, the model was developed using the cases in the training or
learning sample, which, in our study, was 70% of the dataset. The predictive accuracy was
then assessed using the remaining 30% of the dataset. In addition, we have also reported
the applicability domain (AD) for both models.
Finally, the performance of the model was evaluated using the residuals, R and R2,
and other relevant statistics. Regarding the molecular descriptors (MD), we used the
DRAGON 7.0® software to calculate the variables that have been used for the development
of the models. This software suite is able to calculate up to 7500 different descriptors,
belonging to very different classes, such as topological, two-dimensional (2D), three-
dimensional (3D), connectivity, and so on [54]. In order to select the best subset of MD,
we have performed a feature selection process using a forward stepwise methodology [35]
for both models. At the end of this procedure, we were able to develop the pristine and the
carboxylate model using respectively two and three MD belonging to the topological class.
The two MD used in the SWCNT-pristine model are the Narumi geometric topological
index (GNAR) and the electro-topological positive variation (MAXDP). The Narumi index






The MAXDP is calculated as follows:







which is calculated as the maximum positive value of ∆Ii.
Regarding the SWCNT-COOH model, the continuous model was developed using
three MD, one is the same GNAR used for the pristine model. The other two are defined
as follows: The first one is the path/walk Randic shape indices that are calculated by
summing, over the non-H atoms, the ratios of the atomic path count over the atomic walk
count of the same order k and then, dividing by the total number of non-H atoms (nSK).
Since path/walk count ratio is independent of molecular size, these descriptors can be
considered as measures of molecular shape. Dragon calculates path/walk shape indices
from order 2 up to 5, and the index of first order is not provided as the counts of the paths
and walks of length one are equal and, therefore, the corresponding molecular index equals
one for all molecules. The formula in this case is not reported in the Dragon manual.
Finally, the last molecular descriptor used is the so-called lopping centric index (LOC),
which is calculated as the mean information content derived from the pruning partition of
a graph:







where nk is the number of terminal vertices removed at the kth step and nSK is the number
of non-H atoms.
All the information regarding the descriptors employed in the nano-QSTR models
can be retrieved from the Dragon webpage (https://chm.kode-solutions.net/products_
dragon_descriptors.php).
3. Results and Discussion
3.1. CNT Effects on Submitochondrial Particles (SMP)
Herein, we present the in vitro assay on the inhibitory effect of the SWCNT ligands
(SWCNT-pristine, SWCNT-COOH) at the range of concentration of 0.5–5 µg/mL over
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F0-ATPase using isolated rat liver submitochondrial particles (isolated F0F1-ATPase) from
mitochondrial inner membrane. In general, we can see that the tested SWCNT exhibit
high ability to act as F0-ATPase inhibitors (ATP-hydrolysis) at a range of concentration
of 3–5 µg/mL. Besides, a concentration dependence with significant statistical difference
(p < 0.05) when compared with SMP (untreated SMP group) and the DMSO-treated SMP
was observed. We note an oligomycin A-like pattern (positive control group used) for both
SWCNT ligands in a range of concentration of 3–5 µg/mL without significant statistical
difference (p > 0.05) when compared with oligomycin A (Figure 1). According to this,
the treated SMP from mixed CNT ligand (5 µg/mL) plus oligomycin A (1 µM) showed
the strongest F0-ATPase inhibition (p < 0.05) when compared with untreated SMP and the
DMSO-treated SMP, and the remaining CNT-treated SMP (3–5 µg/mL). This may suggest
a strong synergistic effect on F0-ATPase inhibition (mitochondrial nanotoxicity). Details of
these experimental results can be seen in Figure 1.
3.2. Modeling F0ATPase Inhibition Induced by SWCNTs
Herein, molecular docking was carried out in order to evaluate the influence of the
carbon nanotubes (SWCNT-pristine and SWCNT-COOH) on the F0-ATPase inhibition
response. The best docking binding pose from each modeled CNT (SWCNT-pristine,
SWCNT-COOH) theoretically suggests that these CNT could act in the same biophysical
environment as the oligomycin A based on hydrophobic non-covalent interaction (π-π
interactions) involving phenylalanine hydrophobic residues (Phe 55 and Phe 64 of the
chains C, D, and M), which are critically involved in the F0-ATPase inhibition (ATP-
hydrolysis) in the F0-ATPase subunit active binding site, see Figure 2.
Figure 2. (A) Schematic representation of carbon nanotubes (CNT) interacting with isolated rat liver
submitochondrial particles (SMP as F0-ATPase). (B,C) Results of experimental in vitro evaluation
of the F0-ATPase inhibition induced by CNT (i.e., CNT as SWCNT-pristine or SWCNT-COOH)
using F0-ATPase under the different conditions described in the Material and Methods Section as
treatments: (i) untreated submitochondrial particles control (SMP as F0-ATPase), (ii) DMSO-treated
SMP, (iii) CNT-treated SMP (1–5 µg/mL), (iv) oligomycin A-treated SMP (oligomycin A is a specific
F0F1-ATPase inhibitor used as a positive control), and (v) treated SMP mixed with SWCNT or
SWCNT-COOH at concentration of 5 µg/mL + oligomycin A (1 µM) to mimick synergistic effects on
F0-ATPase inhibition, which was performed as an additional control group. Results are representative
of three experiments (n = 3). Symbols (*, **, #) were used to denote statistical differences (p < 0.05)
between the evaluated experimental groups used in the in vitro assay containing the SMP.
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The free energy of binding (FEB) values of the formed docking complexes follow the or-
der: FEB (oligomycin A/F0-ATPase complex) = −9.8 kcal/mol > FEB (SWCNT-COOH/F0-
ATPase complex) = −6.8 kcal/mol ~ FEB (SWCNT-pristine complex) = −5.9 kcal/mol,
with interatomic distance of interaction lower than 5 Å, in all the cases. Besides, we note the
presence of π-π interactions, like Y-shaped and pseudo parallel-displaced motif-orientation
preferences, for both single-walled carbon nanotubes. Besides, more electrostatically
favored interactions in the CNT-sidewall than the CNT-tips were observed in both simula-
tions (SWCNT-pristine and SWCNT-COOH). This was probably due to better orientation
and stability between the planar-benzene-quadrupoles formed between van der Waals sur-
face from the modeled SWCNT and the phenylalanine hydrophobic residues (Phe 55 and
Phe 64) of the F0-ATPase binding site and interacting in the same biophysical environment
as the F0-ATPase-specific inhibitor (oligomycin A) [17]. Please, see Figure 3.
Next, we carried out the theoretical modeling based on the local perturbation re-
sponse scanning maps (LPRS maps). The LPRS maps are based on elastic network models
(ENM models) and have been widely recognized to study relevant conformational changes
promoted from distance-based fluctuations in the alpha carbons (C(α)) of a given target
protein (as F0-ATPase under unbound and bound states) at the atomistic and molecular
level [53]. It is well-known that the ENM models could explain a large number of the
conformational differences based on the perturbation patterns of the network formed by
the target residues evaluated (Phe 55 and Phe 64). In this instance, LPRS maps generate
comprehensive visualizations of the F0-ATPase inhibition response, which allows to evalu-
ate allosteric signal propagations in response to external perturbations under the presence
of a given ligand (i.e., the oligomycin A as a F0-ATPase-specific inhibitor, SWCNT-pristine,
and SWCNT-COOH). The results can be seen in Figure 4.
The results on LPRS maps show that both single-walled carbon nanotubes (SWCNT-
pristine and SWCNT-COOH) promote a significant change in the perturbation patterns of
the network of target residues compared with the physiological condition represented by
the unbound state of F0-ATPase. In this regard, we note abrupt perturbations in several
blocks of residues more pronounced for the SWCNT-pristine (strong F0-ATPase inhibition)
than the SWCNT-COOH (moderate F0-ATPase inhibition) during the interaction with
the F0-ATPase. Interestingly, the LPRS map of the SWCNT-pristine/F0-ATPase complex
mimicked the toxicodynamic behavior of the oligomycin A/F0-ATPase complex, inducing
strong F0-ATPase inhibition (see Figure 4B,C), suggesting a similar pattern of allosteric
network perturbation. However, the LPRS map obtained from the SWCNT-COOH/F0-
ATPase complex (Figure 4D) exhibits a pattern of perturbation less affected when compared
with the physiological condition depicted for the F0F1ATPase unbound state (Figure 4A),
maintaining a certain structural and functional coupling between the residues composing
the F0-ATPase network, suggesting the presence of a moderate nanotoxicity-based F0-
ATPase inhibition. The relevance of these results is that strong local perturbations similar
to those observed in Figure 4A, B are able to induce strong allosteric perturbations in
the j-effector residues from the F0-ATPase receptor, affecting its mitochondrial catalytic
function (ATP-hydrolysis) involving the signal transduction of the perturbations from
the block of i-sensor residues which trigger abnormal signals’ propagation across the
inter-residue network for j-effector F0-ATPase residues. We could suggest that considering
the SWCNT docking position, both ligands (SWCNT-pristine >> SWCNT-COOH) can
theoretically disrupt the H+-proton flux dynamic in the mitochondrial H+-F0-ATPase
subunit, compromising the coupling between oxidative phosphorylation and electron
transport in the respiratory chain, inducing potential bioenergetic dysfunction and the
mitochondria nanotoxicity [9].
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Figure 3. Snapshots selection from molecular docking interactions obtained from the best binding poses of the ligands as (A)
superimposed representation of oligomycin A and SWCNT-pristine, and (B) superimposed representation of oligomycin
and SWCNT-pristine and SWCNT-COOH interacting with critical phenylalanine hydrophobic residues (Phe 55 and Phe 64:
labelled red) which belong to the target chains C, D, and M in the F0-ATPase subunit receptor. Please note that oligomycin
A (labelled green) corresponds to the control simulation experiment used here as a reference due to this ligand being the
specific inhibitor of the F0-ATPase in all cases.
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Figure 4. Perturbation response analysis for the F0-ATPase inhibition response. (A) LPRS map obtained for the unbound
F0-ATPase as the control simulation experiment. Individual LPRS maps obtained from the best docking complexes (in
the bound state for all the ligands tested) with intensity bar color representing the i,j residue perturbations (on the right)
for: (B) oligomycin A/F0-ATPase complex, (C) SWCNT-pristine/F0-ATPase complex, and (D) SWCNT-COOH/F0-ATPase
complex. All the LPRS maps were established in range of the low-frequency normal modes in order to capture relevant
fluctuations associated with F0-ATPase catalytic function across the different conditions simulated.
In order to quantify potential fractal geometrical perturbations, a fractal surface anal-
ysis was carried out to model changes-based perturbations in the geometric surface of
the binding effector residues of the F0-ATPase under unbound and bound states (i.e.,
under SWCNT-pristine and SWCNT-COOH interactions) [9]. Several fractal dimensions
(FDs, namely: DBW, DB+BW, and DW+BW) were calculated using the box-counting methods
from the LPRS maps previously obtained [55]. The Fractal Theory allows the mathe-
matical modeling of the geometric complexity (across multiple scales) and self-similarity
(scale-invariant structure) from non-Euclidean real or virtual objects (such as the tested
SWCNT). One of the most important properties in the fractal modeling is the degree of
self-similarity. Then, a topological fractal dimension near to 2 is categorized-like, high com-
plexity (i.e., high variety of geometrical information after the docking interaction) and low
self-similarity; in contrast, a topological fractal dimension closer to 1 informs about little
complexity and high self-similarity after the docking interaction. Herein, the non-Euclidean
geometrical patterns were included according to the fractal dimension, like FDBW, that
describes the surface geometric perturbations in the border of the LPRS map fractal pat-
tern [55]. The FDB+BW characterizes the surface geometric perturbations on the white
background, and the FDW+BW characterizes the fractal perturbations pattern on the black
background from the LPRS images calculated for each simulation condition, see Figure 5.
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Figure 5. Fractal spectrum based on the box-counting method performed to obtain the slopes of the linear regression yields
from binary black/white LPRS maps image-processing. These slopes represent the fractal dimensions (FD: DBW, DB+BW,
and DW+BW) for the best docking complexes, namely: (A) unbound F0-ATPase, (B) oligomycin A/F0-ATPase complex,
(C) SWCNT-pristine/F0-ATPase complex, and (D) SWCNT-COOH/ F0-ATPase complex.
Herein, the obtained FDs are related to the F0-ATPase surface and backbone non-
Euclidean geometry [9,55]. FDs inform about how the F0-ATPase folding, packing den-
sity, solvent accessibility, and binding interaction properties could be perturbed under
the presence of different ligands forming docking complexes (oligomycin A/F0-ATPase
complex, SWCNT-pristine/F0-ATPase complex, and SWCNT-COOH/F0-ATPase com-
plex). In this context, we suggest that, in the bound state (i.e., during the docking in-
teraction), the SWCNT-pristine led to higher F0F1-ATPase nanotoxicity-based allosteric
perturbations than its carboxylate analogous (SWCNT-COOH) based on their obtained
values for the fractal dimensions (FDBW), such as SWCNT-pristine/F0-ATPase complex
(FDBW = 1.29) < SWCNT-COOH/F0-ATPase complex (FDBW = 1.45), which quantitatively
exhibits very similar features-based fractal dimension (DBW, DBBW, and DWBW) compared
to physiological condition (unbound F0-ATPase (FDBW = 1.45)) used as a control for
comparison purposes. It is well-known that slight variations in the fractal dimension as
observed in the bound state for the docking complexes SWCNT-pristine/F0-ATPase and
SWCNT-COOH/F0-ATPase (Figure 5C, D, respectively) are sufficient to induce changes in
the geometry and roughness of the active site of F0-subunit of the F0F1-ATPase.
These results fit well with the previous LPRS maps, strongly suggesting that the
SWCNT-pristine/F0-ATPase complex (FDBW = 1.29) mimicked the nanotoxicological be-
havior of the specific F0F1-ATPase inhibitor (oligomycin A) with very close calculated
fractal dimension for oligomycin A/F0-ATPase complex (FDBW = 1.32), both lower than
the physiological condition of unbound F0-ATPase cited above (Figure 5A). As previously
cited, a FD ≈ 2 reveals a high variety of geometrical information and low self-similarity,
while FD ≈ 1 represents little complexity and high self-similarity. On the other hand,
the FD values obtained for FDB+BW and FDW+BW remain as unperturbed around 1.85 in all
the cases, revealing high complexity of geometrical information [9,55].
Biology 2021, 10, 171 14 of 22
The results of fractal surface perturbation suggest that the SWCNT-pristine can induce
significant changes in the geometrical selectivity of the F0-ATPase, like oligomycin A. It is
well-known that perturbation (global and local perturbations) in the three-dimensional
spatial arrangement of atoms composing effector residues (j-effector allosteric residues)
of proteins can be studied using their FDs. Fractal surface perturbations could negatively
impact on catalytic function of F0-ATPase, irreversibly affecting the structural proper-
ties of the binding cavities, which are of paramount importance in the complementary
processes like substrate recognition and ligand geometrical specificity. Probably, topologi-
cally perturbed van der Waals fractal surface of F0-ATPase after the docking interaction
with SWCNT-COOH could theoretically explain the moderate mitochondrial nanotoxicity
observed from the SWCNT-COOH/F0-ATPase docking complex (refer to Figure 4A,D).
Lastly, we carried out a nano-quantitative structure–toxicity relationship approach
(Nano-QSRT models) in order to evaluate the influence of additional geometric properties
of the ligands SWCNT-pristine and SWCNT-COOH based on the well-known relationship
between the topology geometry based on the n, m Hamada index with their nanotoxicolog-
ical properties (i.e., SWCNT-mitotoxicity).
3.3. Performed Nano-QSTR Models
As reported in the Material and Methods Section, the Nano-QSTR model for SWCNT-
pristine was developed using only two variables belonging to the topological index category.
The observed versus predicted values and the other relevant statistics are reported in the
Tables 1 and 2, and Figure 6, respectively. In addition, we have also reported the AD
in Figure 7.
Table 1. Results of the Nano-QSTR regression model for mitochondrial F0-ATPase inhibition induced
by SWCNT-pristine.






amchair 3.3 −20.00000 −18.93350 −1.06650 training
amchair 4.4 −19.70000 −18.83954 −0.86046 training
amchair 5.5 −18.80000 −18.77444 −0.02556 training
amchair 6.6 −18.50000 −18.72592 0.22592 validation
amchair 7.7 −18.20000 −18.68908 0.48908 training
amchair 8.8 −17.50000 −18.66083 1.16083 training
amchair 9.9 −17.20000 −18.63872 1.43872 training
chiral 3.2 −17.20000 −16.28865 −0.91135 validation
chiral 4.1 −17.20000 −15.58908 −1.61092 training
chiral 4.2 −17.00000 −15.84427 −1.15573 training
chiral 4.3 −16.30000 −15.96788 −0.33212 training
chiral 5.1 −16.20000 −15.56891 −0.63109 validation
chiral 5.2 −16.20000 −15.44925 −0.75075 training
chiral 5.3 −16.00000 −15.63349 −0.36651 training
chiral 5.4 −16.00000 −15.72809 −0.27191 training
chiral 6.1 −16.00000 −15.26864 −0.73136 validation
chiral 6.2 −15.90000 −15.19863 −0.70137 training
chiral 6.3 −15.90000 −15.37446 −0.52554 training
chiral 6.4 −15.90000 −15.47126 −0.42874 training
chiral 6.5 −15.80000 −15.39773 −0.40227 validation
chiral 7.1 −15.70000 −15.02346 −0.67654 training
chiral 7.2 −15.40000 −15.17288 −0.22712 training
chiral 7.3 −15.40000 −15.10112 −0.29888 training
chiral 7.4 −15.20000 −15.24345 0.04345 validation
chiral 7.5 −15.20000 −15.34078 0.14078 training
chiral 7.6 −15.20000 −15.28875 0.08875 training
chiral 8.1 −15.00000 −15.03210 0.03210 training
chiral 8.2 −15.00000 −14.77537 −0.22463 validation
chiral 8.3 −14.90000 −15.23422 0.33422 training
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Table 1. Cont.






chiral 8.4 −14.80000 −15.08583 0.28583 training
chiral 8.5 −14.70000 −15.15833 0.45833 training
chiral 8.6 −14.70000 −15.24567 0.54567 validation
chiral 8.7 −14.70000 −15.20136 0.50136 training
chiral 9.3 −14.60000 −14.79209 0.19209 training
chiral 9.4 −14.50000 −15.12489 0.62489 training
chiral 9.5 −14.50000 −15.11612 0.61612 validation
chiral 9.6 −14.50000 −15.09848 0.59848 training
chiral 9.7 −14.30000 −15.29203 0.99203 training
zigzag 3.0 −14.30000 −15.37860 1.07860 training
zigzag 4.0 −14.10000 −14.00654 −0.09346 validation
zigzag 5.0 −13.70000 −14.00654 0.30654 training
zigzag 6.0 −13.70000 −13.79221 0.09221 training
zigzag 7.0 −13.60000 −13.62087 0.02087 training
zigzag 8.0 −13.30000 −13.48024 0.18024 validation
zigzag 9.0 −12.90000 −13.36294 0.46294 training
Datasets: training (a) and validation sets (b).






Sum of squares Model 77.70196
Degrees of freedom Model 2
Mean squared errors Model 38.85098
Sum of squares Residual 15.83245
Degrees of freedom Residual 31
Mean squared errors Residual 0.510724
F 76.07035
P 0
As can be seen in the Tables 1 and 2, the Nano-QSTR model shows an overall high
accuracy and goodness of fit, thus indicating that this model can be used for a continuous
prediction of the likelihood of induced mitochondria nanotoxicity inhibition on F0F1-
ATPase by interaction with SWCNT-pristine (f(FEB_1)). In this regard, the best Nano-QSTR
regression model is based on the linear Equation (9) as:
f(FEB_1) = −8.24425(GNar) + 0.614121(MAXDP)− 2.87142 (9)
Afterward, we performed a Nano-QSTR model for SWCNT-COOH. For this instance,
was carried out a QSTR regression model by using three variables, as in the case of the
previous model (i.e., using SWCNT-pristine). Herein, the results obtained on observed
versus predicted values, and the other relevant statistical parameters, are summarized in
the Tables 3 and 4, and Figure 8, respectively. In addition, we have also reported the AD in
Figure 9.
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Figure 6. Results of observed versus predicted values obtained for the Nano-QSTR regression model
performed for the SWCNT-pristine data.
Figure 7. Applicability domain for SWCNT-pristine data.
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Table 3. Results of the Nano-QSTR regression model for mitochondrial F0-ATPase inhibition induced
by SWCNT-COOH.






amchair 3.3 −34.80000 −33.04305 −1.75695 training
amchair 4.4 −33.10000 −31.92664 −1.17336 training
amchair 5.5 −32.30000 −31.36844 −0.93156 training
amchair 6.6 −32.30000 −30.81023 −1.48977 validation
amchair 7.7 −29.80000 −30.53113 0.73113 training
amchair 8.8 −29.10000 −30.25203 1.15203 training
amchair 9.9 −29.00000 −29.97293 0.97293 training
chiral 3.2 −28.50000 −26.92826 −1.57174 validation
chiral 4.1 −27.90000 −26.16358 −1.73642 training
chiral 4.2 −27.60000 −27.01059 −0.58941 training
chiral 4.3 −26.90000 −25.00316 −1.89684 training
chiral 5.1 −26.70000 −28.51704 1.81704 validation
chiral 5.2 −26.60000 −24.71436 −1.88564 training
chiral 5.3 −26.40000 −25.08549 −1.31451 training
chiral 5.4 −26.40000 −24.19447 −2.20553 training
chiral 6.1 −26.30000 −27.20385 0.90385 validation
chiral 6.2 −25.90000 −24.54620 −1.35380 training
chiral 6.3 −25.40000 −25.47553 0.07553 training
chiral 6.4 −25.00000 −24.13724 −0.86276 training
chiral 6.5 −24.80000 −24.44496 −0.35504 validation
chiral 7.1 −24.70000 −25.21534 0.51534 training
chiral 7.2 −24.60000 −26.28422 1.68422 training
chiral 7.3 −24.50000 −24.04522 −0.45478 training
chiral 7.4 −24.30000 −24.52728 0.22728 validation
chiral 7.5 −24.30000 −23.88676 −0.41324 training
chiral 7.6 −24.30000 −23.32855 −0.97145 training
chiral 8.1 −24.10000 −26.95336 2.85336 training
chiral 8.2 −24.10000 −23.51211 −0.58789 validation
chiral 8.3 −24.10000 −25.39320 1.29320 training
chiral 8.4 −24.00000 −24.63822 0.63822 training
chiral 8.5 −23.70000 −24.27680 0.57680 training
chiral 8.6 −23.50000 −22.90990 −0.59010 validation
chiral 8.7 −23.50000 −24.89841 1.39841 training
chiral 9.3 −23.00000 −23.42979 0.42979 training
chiral 9.4 −22.60000 −24.13724 1.53724 training
chiral 9.5 −22.50000 −23.71859 1.21859 validation
chiral 9.6 −22.40000 −23.16039 0.76039 training
chiral 9.7 −22.20000 −23.53151 1.33151 training
zigzag 3.0 −22.10000 −25.42752 3.32752 training
zigzag 4.0 −21.70000 −20.86901 −0.83099 validation
zigzag 5.0 −21.50000 −20.86901 −0.63099 training
zigzag 6.0 −21.40000 −20.17126 −1.22874 training
zigzag 7.0 −21.10000 −19.61305 −1.48695 training
zigzag 8.0 −20.90000 −19.19440 −1.70560 validation
zigzag 9.0 −17.30000 −18.91530 1.61530 training
Datasets: training (a) and validation sets (b).






Sum of squares Model 366.1187
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Table 4. Cont.
Statistical Parameters Value
Degrees of freedom Model 3
Mean squared errors Model 122.0396
Sum of squares Residual 67.46364
Degrees of freedom Residual 30
Mean squared errors Residual 2.248788
F 54.26905
p 0.000000
Figure 8. Results of observed versus predicted values obtained for the Nano-QSTR regression model
performed for the SWCNT-COOH data.
Figure 9. Applicability domain for SWCNT-COOH data.
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For the case of the SWCNT-COOH dataset, the final Nano-QSTR regression model
to predict the mitochondrial F0-ATPase inhibition (f(FEB_2)) is represented by the linear
Equation (10) as:
f(FEB_2) = −1005.47(GNar)− 1401.69(PW5)− 139.55(LOC)− 2326.4 (10)
Overall, the proposed methodologies rigorously obey the Organization for Economic
Co-operation and Development (OECD) and the International Organization for Standard-
ization guidelines for development of alternative methods for Computational Nanotoxicol-
ogy [56].
4. Conclusions
In the present study, we presented a combination of experimental and computa-
tional approaches to tackle the nanotoxicity of pristine and oxidized single-walled carbon
nanotubes (SWCNT-pristine, SWCNT-COOH) based on the mitochondrial F0F1-ATPase
inhibition. Experimental evidences supported that the in vitro F0F1-ATPase inhibition
responses in submitochondrial particles (SMP) are strongly dependent on the higher level
of concentration (from 3 to 5 µg/mL) in both types of single-walled carbon nanotubes
(SWCNT-pristine and SWCNT-COOH) evaluated. In addition, both types of carbon nan-
otubes show an interaction inhibition pattern for the F0F1-ATPase enzyme, similar to the
oligomycin A (specific F0F1-ATPase inhibitor). On the other hand, the best binding pose
for the obtained complexes fit well with the previous experimental results. The free energy
of binding (FEB values) for the formed docking complexes followed the affinity order:
FEB (oligomycin A/F0-ATPase complex) = −9.8 kcal/mol > FEB (SWCNT-COOH/F0-
ATPase complex) = −6.8 kcal/mol ~ FEB (SWCNT-pristine complex) = −5.9 kcal/mol,
with relevant interatomic distance of interaction lower than 5 Å, in all the cases, and with
predominance of van der Waals hydrophobic interactions with critical F0-ATPase bind-
ing site residues (Phe 55 and Phe 64) belonging to the same biophysical environment as
the oligomycin A inhibitor. In addition, results on elastic network models (LPRS maps)
show that the SWCNT-pristine can promote an abrupt perturbation in several blocks of
residues (strong F0-ATPase nanotoxicity inhibition), more pronounced than the analogous
SWCNT-COOH (moderate F0-ATPase nanotoxicity inhibition), triggering perturbations on
the allosteric responses and abnormal signals’ propagation across the inter-residue network
of the F0F1-ATPase. In accordance with this, results on the fractal surface of interactions
based on the formed docking complexes (SWCNT-pristine/F0F1-ATPase >> SWCNT-
COOH/F0F1-ATPase) suggest that the SWCNT-pristine interactions topologically affect
the van der Waals fractal surface and geometric properties of F0-ATPase compared to
physiological condition (unbound F0-ATPase). We suggest that the SWCNT-pristine per-
turbations could negatively impact on catalytic function of F0-ATPase (mitochondrial
ATP-hydrolysis), by irreversibly affecting the structural properties of the binding cavities in
the F0-subunit. Lastly, the predictive Nano-QSTR models showed that a linear correlation
between SWCNT topology and the nanotoxicity induced was present and can be predicted
using a Nano-QSTR approach.
Finally, these results open new opportunities toward to the better understanding of
the molecular nanotoxicity mechanisms, relevance of mitotarget drug discovery, and ra-
tional drug design-based nanotechnology with potential biomedical application in preci-
sion nanomedicine.
Supplementary Materials: The following are available online at https://www.mdpi.com/2079-773
7/10/3/171/s1, Figure S1. Characterization of the SWCNT-samples based on Fourier-transformed
infrared (FT-IR spectrum).
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